Drugs and FDA
FDA approves generic injectable lenacapavir for HIV prevention
An Indian company has pledged to sell injectable lenacapavir in low- and middle-income countries for $40 a year.
The original reports on this story are listed below.
More top stories
Infectious disease
Washington resident dies of H5N1 after exposure to infected cattle
The CDC identified the virus as H5N1, and county officials said the resident had underlying health conditions and was hospitalized.
Drugs and FDA
FDA approves Inovio’s Voceryq for adults with recurrent respiratory papillomatosis
Voceryq received accelerated FDA approval to reduce surgery frequency in adults with recurrent respiratory papillomatosis, but treatment starts with surgery to remove visible growths.
Outbreaks
Pennsylvania mounts measles outreach amid low vaccination coverage
Pennsylvania’s latest count was 1,398 measles cases, as officials offered pop-up clinics and mailings in Lancaster County.